(CELH) Celsius Holdings - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US15118V2079
Stock: Energy Drinks, Hydration Powders, Functional Beverages
Total Rating 48
Risk 38
Buy Signal -0.61
| Risk 5d forecast | |
|---|---|
| Volatility | 61.1% |
| Relative Tail Risk | -14.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.75 |
| Alpha | 14.47 |
| Character TTM | |
|---|---|
| Beta | 1.537 |
| Beta Downside | 1.082 |
| Drawdowns 3y | |
|---|---|
| Max DD | 77.86% |
| CAGR/Max DD | 0.17 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 166.0
Technicals: volatileDescription: CELH Celsius Holdings March 05, 2026
Celsius Holdings, Inc. manufactures and distributes functional energy drinks globally. The companys product portfolio includes CELSIUS branded energy drinks, specialized amino-infused beverages, and powdered hydration products. The functional beverage market is a growing segment within the broader non-alcoholic beverage industry.
Distribution channels are extensive, encompassing direct-to-store delivery, independent distributors, and a wide array of retail outlets including supermarkets, convenience stores, and e-commerce platforms. This multi-channel approach is common for consumer packaged goods companies aiming for broad market penetration.
To further understand CELHs market position, consider exploring its growth metrics on ValueRay.
Headlines to watch out for
- Distribution expansion into new markets drives revenue growth
- Increased competition in energy drink market impacts pricing
- Raw material cost fluctuations affect profit margins
- Regulatory scrutiny on energy drink ingredients poses risk
- Consumer health trends influence product demand
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 108.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -7.24 > 1.0 |
| NWC/Revenue: 29.12% < 20% (prev 70.75%; Δ -41.63% < -1%) |
| CFO/TA 0.07 > 3% & CFO 359.4m > Net Income 108.0m |
| Net Debt (271.1m) to EBITDA (189.9m): 1.43 < 3 |
| Current Ratio: 1.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (237.2m) vs 12m ago 25.65% < -2% |
| Gross Margin: 50.39% > 18% (prev 0.50%; Δ 4.99k% > 0.5%) |
| Asset Turnover: 73.05% > 50% (prev 76.72%; Δ -3.68% > 0%) |
| Interest Coverage Ratio: 3.28 > 6 (EBITDA TTM 189.9m / Interest Expense TTM 49.0m) |
Altman Z'' 1.45
| A: 0.14 (Total Current Assets 1.81b - Total Current Liabilities 1.08b) / Total Assets 5.12b |
| B: 0.03 (Retained Earnings 175.9m / Total Assets 5.12b) |
| C: 0.05 (EBIT TTM 160.5m / Avg Total Assets 3.44b) |
| D: 0.08 (Book Value of Equity 179.2m / Total Liabilities 2.18b) |
| Altman-Z'' Score: 1.45 = BB |
Beneish M -0.84
| DSRI: 1.51 (Receivables 755.5m/270.3m, Revenue 2.52b/1.36b) |
| GMI: 1.00 (GM 50.39% / 50.18%) |
| AQI: 3.05 (AQ_t 0.63 / AQ_t-1 0.21) |
| SGI: 1.86 (Revenue 2.52b / 1.36b) |
| TATA: -0.05 (NI 108.0m - CFO 359.4m) / TA 5.12b) |
| Beneish M-Score: -0.84 (Cap -4..+1) = D |
What is the price of CELH shares?
As of March 20, 2026, the stock is trading at USD 42.96 with a total of 4,974,689 shares traded.
Over the past week, the price has changed by -1.65%, over one month by -2.65%, over three months by +0.37% and over the past year by +34.67%.
Over the past week, the price has changed by -1.65%, over one month by -2.65%, over three months by +0.37% and over the past year by +34.67%.
Is CELH a buy, sell or hold?
Celsius Holdings has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy CELH.
- StrongBuy: 8
- Buy: 6
- Hold: 6
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the CELH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 68.1 | 58.4% |
| Analysts Target Price | 68.1 | 58.4% |
CELH Fundamental Data Overview March 20, 2026
P/E Trailing = 166.0
P/E Forward = 28.5714
P/S = 4.2533
P/B = 9.5616
P/EG = 0.6929
Revenue TTM = 2.52b USD
EBIT TTM = 160.5m USD
EBITDA TTM = 189.9m USD
Long Term Debt = 669.9m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 669.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 271.1m USD (from netDebt column, last quarter)
Enterprise Value = 10.97b USD (10.70b + Debt 669.9m - CCE 398.9m)
Interest Coverage Ratio = 3.28 (Ebit TTM 160.5m / Interest Expense TTM 49.0m)
EV/FCF = 33.92x (Enterprise Value 10.97b / FCF TTM 323.4m)
FCF Yield = 2.95% (FCF TTM 323.4m / Enterprise Value 10.97b)
FCF Margin = 12.86% (FCF TTM 323.4m / Revenue TTM 2.52b)
Net Margin = 4.29% (Net Income TTM 108.0m / Revenue TTM 2.52b)
Gross Margin = 50.39% ((Revenue TTM 2.52b - Cost of Revenue TTM 1.25b) / Revenue TTM)
Gross Margin QoQ = 47.37% (prev 51.34%)
Tobins Q-Ratio = 2.14 (Enterprise Value 10.97b / Total Assets 5.12b)
Interest Expense / Debt = 1.89% (Interest Expense 12.7m / Debt 669.9m)
Taxrate = 13.62% (17.0m / 125.0m)
NOPAT = 138.6m (EBIT 160.5m * (1 - 13.62%))
Current Ratio = 1.68 (Total Current Assets 1.81b / Total Current Liabilities 1.08b)
Debt / Equity = 0.23 (Debt 669.9m / totalStockholderEquity, last quarter 2.94b)
Debt / EBITDA = 1.43 (Net Debt 271.1m / EBITDA 189.9m)
Debt / FCF = 0.84 (Net Debt 271.1m / FCF TTM 323.4m)
Total Stockholder Equity = 2.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.14% (Net Income 108.0m / Total Assets 5.12b)
RoE = 4.66% (Net Income TTM 108.0m / Total Stockholder Equity 2.32b)
RoCE = 5.37% (EBIT 160.5m / Capital Employed (Equity 2.32b + L.T.Debt 669.9m))
RoIC = 8.54% (NOPAT 138.6m / Invested Capital 1.62b)
WACC = 10.99% (E(10.70b)/V(11.37b) * Re(11.58%) + D(669.9m)/V(11.37b) * Rd(1.89%) * (1-Tc(0.14)))
Discount Rate = 11.58% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.15%
[DCF] Terminal Value 72.16% ; FCFF base≈289.8m ; Y1≈357.5m ; Y5≈608.9m
[DCF] Fair Price = 23.72 (EV 6.37b - Net Debt 271.1m = Equity 6.10b / Shares 257.0m; r=10.99% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 35.02 | EPS CAGR: 34.61% | SUE: 0.93 | # QB: 2
Revenue Correlation: 89.32 | Revenue CAGR: 56.86% | SUE: 2.12 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.47 | Chg7d=+0.000 | Chg30d=-0.007 | Revisions Net=+1 | Analysts=16
EPS current Year (2026-12-31): EPS=1.63 | Chg7d=+0.004 | Chg30d=+0.080 | Revisions Net=+9 | Growth EPS=+21.9% | Growth Revenue=+35.0%
EPS next Year (2027-12-31): EPS=2.06 | Chg7d=+0.004 | Chg30d=+0.180 | Revisions Net=+9 | Growth EPS=+25.9% | Growth Revenue=+10.0%
[Analyst] Revisions Ratio: +0.11 (5 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 11.0% (Discount Rate 11.6% - Earnings Yield 0.6%)
[Growth] Growth Spread = +13.3% (Analyst 24.3% - Implied 11.0%)
P/E Forward = 28.5714
P/S = 4.2533
P/B = 9.5616
P/EG = 0.6929
Revenue TTM = 2.52b USD
EBIT TTM = 160.5m USD
EBITDA TTM = 189.9m USD
Long Term Debt = 669.9m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 669.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 271.1m USD (from netDebt column, last quarter)
Enterprise Value = 10.97b USD (10.70b + Debt 669.9m - CCE 398.9m)
Interest Coverage Ratio = 3.28 (Ebit TTM 160.5m / Interest Expense TTM 49.0m)
EV/FCF = 33.92x (Enterprise Value 10.97b / FCF TTM 323.4m)
FCF Yield = 2.95% (FCF TTM 323.4m / Enterprise Value 10.97b)
FCF Margin = 12.86% (FCF TTM 323.4m / Revenue TTM 2.52b)
Net Margin = 4.29% (Net Income TTM 108.0m / Revenue TTM 2.52b)
Gross Margin = 50.39% ((Revenue TTM 2.52b - Cost of Revenue TTM 1.25b) / Revenue TTM)
Gross Margin QoQ = 47.37% (prev 51.34%)
Tobins Q-Ratio = 2.14 (Enterprise Value 10.97b / Total Assets 5.12b)
Interest Expense / Debt = 1.89% (Interest Expense 12.7m / Debt 669.9m)
Taxrate = 13.62% (17.0m / 125.0m)
NOPAT = 138.6m (EBIT 160.5m * (1 - 13.62%))
Current Ratio = 1.68 (Total Current Assets 1.81b / Total Current Liabilities 1.08b)
Debt / Equity = 0.23 (Debt 669.9m / totalStockholderEquity, last quarter 2.94b)
Debt / EBITDA = 1.43 (Net Debt 271.1m / EBITDA 189.9m)
Debt / FCF = 0.84 (Net Debt 271.1m / FCF TTM 323.4m)
Total Stockholder Equity = 2.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.14% (Net Income 108.0m / Total Assets 5.12b)
RoE = 4.66% (Net Income TTM 108.0m / Total Stockholder Equity 2.32b)
RoCE = 5.37% (EBIT 160.5m / Capital Employed (Equity 2.32b + L.T.Debt 669.9m))
RoIC = 8.54% (NOPAT 138.6m / Invested Capital 1.62b)
WACC = 10.99% (E(10.70b)/V(11.37b) * Re(11.58%) + D(669.9m)/V(11.37b) * Rd(1.89%) * (1-Tc(0.14)))
Discount Rate = 11.58% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.15%
[DCF] Terminal Value 72.16% ; FCFF base≈289.8m ; Y1≈357.5m ; Y5≈608.9m
[DCF] Fair Price = 23.72 (EV 6.37b - Net Debt 271.1m = Equity 6.10b / Shares 257.0m; r=10.99% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 35.02 | EPS CAGR: 34.61% | SUE: 0.93 | # QB: 2
Revenue Correlation: 89.32 | Revenue CAGR: 56.86% | SUE: 2.12 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.47 | Chg7d=+0.000 | Chg30d=-0.007 | Revisions Net=+1 | Analysts=16
EPS current Year (2026-12-31): EPS=1.63 | Chg7d=+0.004 | Chg30d=+0.080 | Revisions Net=+9 | Growth EPS=+21.9% | Growth Revenue=+35.0%
EPS next Year (2027-12-31): EPS=2.06 | Chg7d=+0.004 | Chg30d=+0.180 | Revisions Net=+9 | Growth EPS=+25.9% | Growth Revenue=+10.0%
[Analyst] Revisions Ratio: +0.11 (5 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 11.0% (Discount Rate 11.6% - Earnings Yield 0.6%)
[Growth] Growth Spread = +13.3% (Analyst 24.3% - Implied 11.0%)